[Comparison of active and passive fixation of steroid emitting atrial electrodes].
Steroid-eluting screw-in leads (CapSure Fix 4068, Medtronic; n = 14) were compared to the same lead as a J-shaped tined electrode (CapSure SP 4524, Medtronic; n = 27, implanted in the atrium in patients receiving dual-chamber pacemakers. Follow-up were at discharge and after 1 month. Implantation (screw-in lead: 84 +/- 18 min; tined lead: 81 +/-29 min) and fluoroscopy times (screw-in lead: 7.3 +/- 4.9 min; tined lead 9.2 +/- 7.0 min) were similar in the two groups. At implant, P-wave amplitudes were similar with 4.8 +/- 1.6 mV (screw-in lead) and 4.0 +/- 2.6 mV (tinted lead), respectively. Compared to tined leads, the screw-in leads had higher pacing thresholds at 0.5 ms pulse duration (screw-in lead: 0.74 +/- 0.32 V; tined lead: 0.55 +/- 0.15 V; p = 0.02) as well as higher impedance (screw-in lead: 566 +/- 93 ohms; tined lead: 470 +/- 99 ohms; p = 0.01). Pulse duration thresholds at 2.5 V pulse amplitude were neither different at discharge (screw-in lead: 0.07 +/- 0.04 ms; tined lead: 0.06 +/- 0.05 ms) nor after 1 month (screw-in lead: 0.09 +/- 0.04 ms; tined lead: 0.06 +/- 0.06 ms). P-wave amplitudes > or = mV were observed at discharge in 14/14 (screw-in lead) 21/27 patients (tined lead), respectively, and after 1 month in 13/14 (screw-in lead) and 22/27 (tined lead) patients, respectively. Impedance of the screw-in lead was significantly higher with 693 +/- 84 ohms at discharge and 691 +/- 79 ohms after 1 month compared to the tined lead with 520 +/- 81 and 574 +/- 62 ohms (p = 0.001). No lead dislodgment was reported during follow-up.


CONCLUSIONS
For the studied steroid-eluting leads active and passive fixation had neither at implantation nor during 1-month follow up any influence on P-wave amplitude. At similar pulse duration thresholds, impedance of the screw-in lead was significantly higher than for the tined lead. Higher impedance additionally reduces pacing current, if similar pacing impulses are delivered.
Schuchert
A
A
Medizinische Klinik und Poliklinik Abteilung für Kardiologie Universitäts-Krankenhaus Eppendorf Hamburg.
van Langen
H
H
Michels
K
K
Meinertz
T
T
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D004562:Electrocardiography / Q000187:drug effects*; D004567:Electrodes, Implanted; D004867:Equipment Design; D005260:Female; D006327:Heart Block / Q000503:physiopathology / Q000628:therapy*; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D012804:Sick Sinus Syndrome / Q000503:physiopathology / Q000628:therapy*; D012815:Signal Processing, Computer-Assisted; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone
Vergleich aktiver und passiver Fixation bei steroidfreisetzenden Vorhofelektroden.